Q4 2025 earnings call: ivonescimab Phase III updates, FDA PDUFA timeline, interim PFS in Q2 2026, cash position—read now.

Case-cohort study designs represent a cost-effective and efficient strategy for analysing time-to-event data, particularly when the event of interest is rare. By selecting a random subcohort along ...

Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study Among 58,358 California ...

A recent study published in Engineering has shed new light on the relationship between cholesterol levels and mortality risks. The research, conducted by a team of scientists from multiple ...

Discover how low cholesterol levels might actually pose health risks! A new study in Engineering reveals that both low and decreasing cholesterol levels are linked to higher mortality risks, ...